ART Fertility Clinics appoints Dr. Somesh Mittal as CEO, India
Delhi NCR, 4th July 2022: ART Fertility Clinics, India today announced the appointment of Dr. Somesh Mittal as their Chief Executive Officer (CEO), India. Dr. Somesh Mittal has previously managed Multiple backed Vikram Hospital as CEO and was associated with Fortis Escorts Heart Institute as zonal director. He is also an alumnus of the University of Delhi’s Faculty of Management Studies.
Commenting on the appointment, Suresh Soni, Global Chief Executive Officer, ART Fertility Clinics said, “Dr. So mesh Mittal brings just the right kind of experience that we were looking for. Being a trained surgeon himself, he has successfully led several large healthcare organizations from the front. His educational background and quali fications and experience are a unique mix, as ART Fertility Clinics, India plans to expand its network to twelve high-end centres in the next year”
Prof. Dr. Human Fatemi, MD, Ph.D., Group Medical Director, ART Fertility Clinics said, “Infertility in India is inc reasing at a rapid pace and it is estimated that nearly thirty million Indian couples need assisted reproduction. Beyond the numbers, the fertility patterns in India are also undergoing a change and more young couples are see king these modern reproductive therapies. ART Fertility Clinics has a deep commitment to India. Under the lead ership of Dr. Somesh Mittal, we would continue to provide its highest standard and globally acknowledged me dical, clinical, diagnostic, and psychological support to Indians in need of assisted reproduction.” Prof. Dr. Human Fatemi has more than 200 original research papers in high-impact science journals in his name and continues to research the various aspects of human infertility.
Commenting on his appointment, Dr. Somesh Mittal said, “India is in need of global standard assisted reproduc tion and ART Fertility Clini cs brings the right kind of expertise and advancement to it. They adhe e to the hig hest clinical practice standards and patient care protocols that match the best in class from the world while ma intaining the hig hest ethical standards. The highly qualified doctors, with international peer-reviewed original research papers in their names, are known for their professional excellence in patient care. I am very excited to join this august organization”
ART Fertility Clinics in its six centres in India offer complex reprodu cti ve treatments like In Vitro Fertilization (IVF), Intra-Cytoplasmic Sperm Injection (ICSI), Intra Uterine Insemination (IUI), Endometrial Recepti vity Anal ysis (ERA), Percutaneous Epididymal Sperm Aspiration (PES A). Their selfpregnancy rates of 71% are equivalent to the best-in-class global success rates. It also plans to launch clinics in Europe and other parts of Asia in the se cond half of 2022
About ART Fertility Clinics:
ART Fertility Clinics was started as an extension of IVI RMA Global in 2015 under the brand name IVI Middle Eas t. In Jan 2020, IVI RMA divested its ownership to Gulf Capital and the entity was rechristened as ART Fertility Cl inics. Since its inception, ART Fertility Clinics has been led by Mr. Suresh Soni, Global Chief Executive Officer, an d Prof. Dr. Human Fatemi, Group Medical Director (MD, Ph.D. at the University of Brussels, Belgium). Dr. Fatemi, a gynaecologist and a reproductive endocrinologist by training, is recognized as a subspecialist in Reproductive Medicine and Surgery by the European Society of Human Reproduction (ESHRE) and the European Board and College of Obstetrics and Gynaecology (EBCOG).
In the past seven years, ART Fertility Clinics has established Clinics in India, Abu Dhabi, Muscat, and Dubai and has become the leading institute for Human Reproductive Medicine in the Middle East.
